Generation of pathogenic TPP1 mutations in human stem cells as a model for neuronal ceroid lipofuscinosis type 2 disease
Neuronal ceroid lipofuscinosis type 2 (CLN2 disease) is an autosomal recessive neurodegenerative disorder generally with onset at 2 to 4 years of age and characterized by seizures, loss of vision, progressive motor and mental decline, and premature death. CLN2 disease is caused by loss-of-function m...
Main Authors: | Li Ma, Adriana M. Prada, Michael Schmidt, Eric M. Morrow |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | Stem Cell Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1873506121001690 |
Similar Items
-
Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis
by: Gemma Gomez-Giro, et al.
Published: (2019-12-01) -
Modelling of Neuronal Ceroid Lipofuscinosis Type 2 in <i>Dictyostelium discoideum</i> Suggests That Cytopathological Outcomes Result from Altered TOR Signalling
by: Paige K. Smith, et al.
Published: (2019-05-01) -
A study of neuronal ceroid lipofuscinosis proteins CLN5 and CLN8
by: De Silva, Weerakonda Arachchige Bhagya Nilukshi
Published: (2017) -
Next-Generation Sequencing Analysis Reveals Novel Pathogenic Variants in Four Chinese Siblings With Late-Infantile Neuronal Ceroid Lipofuscinosis
by: Xiao-Tun Ren, et al.
Published: (2019-04-01) -
Genome editing using CRISPR/ Cas9 system: a practical guide
by: A. G. Menzorov, et al.
Published: (2017-02-01)